The Biomedical Diagnostics Institute (BDI) is an academic–business–clinical partnership carrying out cutting-edge research programmes on the development of next-generation biomedical diagnostic devices. Our vision is to develop diagnostic and monitoring devices that directly address specific unmet clinical needs and translate these into the clinical setting.
The BDI comprises scientists and engineers working across five universities, in collaboration with clinicians based in six hospitals in Dublin and Galway. Since its establishment in 2005, this multidisciplinary BDI team has built significant IP and expertise in assay development, molecular diagnostics, lab-on-a-chip devices and high performance sensor development. This may be used to the advantage of industry partners experiencing R&D challenges in biomarker validation, assay development and new diagnostic product development, with a particular focus on nearpatient/point-of-care testing. The BDI has a strong project management ethos, employing project managers who ensure clear project scoping and that objectives are met in an efficient manner. Through its clinical collaborators, the BDI has access to patient cohorts in disease areas such as cancer, cardiovascular disease, infectious disease and chronic inflammatory conditions such as rheumatoid arthritis. This facilitates device/assay verification in appropriate patient samples and, importantly, in dedicated clinical research centre facilities.
- Immunoassay development
- Sensor technology
- Lab on a chip/microfluidic platforms
- Molecular diagnostics
- Assay reagent development
Research performed by:
- The Royal College of Surgeons in Ireland
- Trinity College Dublin
- NUI Galway
- Tyndall National Institute